Manulife Investment Management

In the ever-evolving economic landscape, the debate between a short recession and a prolonged stagnation, or "soft landing," has taken center stage. What Happened: Frances Donald, chief economist at Manulife Investment Management (NYSE: MFC), recently offered a fresh perspective on...

Biopharma M&A activity scaled record highs in 2019, with a few mega mergers announced involving names such as Bristol-Myers Squibb Co (NYSE: BMY), Roche Holdings AG Basel ADR (OTC: RHHBY) and AbbVie Inc (NYSE: ABBV). It's feared that the frenetic pace of M&A in the sector could slow...